(Q37270423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

PTEN signaling in brain: neuropathology and tumorigenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

S J Baker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

1 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

5416-5430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18794877%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2008.239

14 January 2020

exact match

0 references

cites work

Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN methylation and expression in glioblastomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Evidence That 3-Phosphoinositide-dependent Protein Kinase-1 Mediates Phosphorylation of p70 S6 Kinasein Vivoat Thr-412 as well as Thr-252

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The TOR pathway: a target for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN regulates Mdm2 expression through the P1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN function in normal and neoplastic growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Role for Akt3/protein kinase Bgamma in attainment of normal brain size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN: one gene, many syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN mutation in a family with Cowden syndrome and autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PIK3CA mutations in glioblastoma multiforme.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Correlation among pathology, genotype, and patient outcomes in glioblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pten regulates neuronal arborization and social interaction in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Genome-wide atlas of gene expression in the adult mouse brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Genetic pathways to glioblastoma: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Gene expression profiling and genetic markers in glioblastoma survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Phase II trial of gefitinib in recurrent glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

High frequency of mutations of the PIK3CA gene in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The LKB1 tumor suppressor negatively regulates mTOR signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Ras, PI(3)K and mTOR signalling controls tumour cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN: life as a tumor suppressor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Identification of human brain tumour initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Regulation of PTEN transcription by p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Function of PTEN during the formation and maintenance of neuronal circuits in the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN controls tumor-induced angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The genetic basis of tuberous sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239

The molecular and genetic basis of neurological tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.239